Pharmaceutical / Drug Definition :
Thought to antagonize dopamine and serotonin type 2 in CNS. Also antagonizes muscarinic receptors in respiratory tract, causing cholinergic activation.
In the United States, Olanzapine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Olanzapine.
Registrar Corp assists Olanzapine companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Olanzapine (Olanzapine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Olanzapine (Olanzapine Suppliers)
- Processors Olanzapine
- Repackers Olanzapine
- Relabelers Olanzapine
- Exporters Olanzapine
- Importers Olanzapine
For more information about Olanzapine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.